366
Participants
Start Date
January 31, 2008
Primary Completion Date
March 31, 2009
Study Completion Date
September 30, 2009
Low Strength IDP-107
Once a day for 12 weeks
High Strength IDP-107
Once a day for 12 weeks
Placebo Comparator
Once a day for 12 weeks
DermResearchCenter of New York, Inc., Stony Brook
Dermatology Associates of Rochester, Rochester
Virginia Clinical Research, Inc., Norfolk
University of North Carolina Hospitals and School of Medicine, Chapel Hill
FXM Research Corp., Miami
Michigan Center for Skin Care Research, Clinton Township
Hamzavi Dermatology, Fort Gratiot
Madison Skin & Research, Inc., Madison
Minnesota Clinical Study Center, Fridley
Skin Specialist, PC, Omaha
Burke Pharmaceutical Research, Hot Springs
Dermatology Research of Arkansas, PLLC, Little Rock
University of Oklahoma Health Sciences Center, Oklahoma City
Arlington Research Center, Inc., Arlington
The Center for Skin Research, Houston
J & S Studies, Inc., Bryan
DermResearch, Inc., Austin
Cherry Creek Research, Inc., Denver
South Valley Dermatology, West Jordan
Academic Dermatology Associates, Albuquerque
Clinical Science Institute, Santa Monica
RADY Children's Hospital - San Diego, San Diego
Solano Clinical Research, Vallejo
Oregon Dermatology and Research Center, Portland
Premier Clinical Research, Spokane
Lead Sponsor
Dow Pharmaceutical Sciences
INDUSTRY